Company Data
Monte Rosa Therapeutics Inc.
Ticker
GLUE
Current Price
$4.8 -0.62%
Market Cap
$296.4M
Price Target
Refer to Report
Volume
480.4K
52wk Range
$3.5001 - $12.4
Overview
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.